Results 101 to 110 of about 34,537 (182)

Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival. [PDF]

Liver Int
Bienvenue I, Roux O, Coilly A, Abergel A, Antonini T, Artzner T, Boillot O, Chermak F, Conti F, Dharancy S, Duvoux C, Elkrief L, Farrugia M, Francoz C, Giguet B, Hardwigsen J, Houssel-Debry P, Hilleret MN, Kamar N, Latournerie M, Meszaros M, Radenne S, Roche B, Salamé E, Verhoeven-Weil D, Samuel D, Zoulim F, Dumortier J, Villeret F.   +28 more
europepmc   +1 more source

Baseline Data on Viral Suppression, Treatment Adherence and Mental Health in Peripartum Girls and Young Women With HIV in Zimbabwe. [PDF]

J Int AIDS Soc
Chawana-Mutingwende TD, Ngara B, Mudadi LS, Tauya TT, Sibanda M, Mutambanengwe-Jacob M, Andifasi P, Malunda B, Chidemo T, Mapfunde A, Nyakudya S, Mufumisi AZ, Chirenda TH, Chitambo T, Nderecha WTS, Murandu C, Gwande M, Muringayi K, Micah Bongo R, Okochi H, Kuncze K, Mushavi A, Willis N, Webb K, Gandhi M, Stranix-Chibanda L.   +25 more
europepmc   +1 more source

Tenofovir, Interferon Pathways, and Mucosal Immunity: Implications for People Living With HIV. [PDF]

Am J Reprod Immunol
Hladik F, Hughes SM, Levy CN, Creighton RL, Mackelprang R, Gornalusse GG.   +5 more
europepmc   +1 more source

Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study. [PDF]

J Clin Med
Fukushima M, Miuma S, Nakao Y, Sasaki R, Haraguchi M, Miyaaki H.   +5 more
europepmc   +1 more source

Real-world pharmacovigilance of drug-induced osteoporosis: a focus on antiretroviral therapy and toxicological mechanisms in the elderly. [PDF]

Front Pharmacol
Liu X, Gong Y, Liu L, Wang X, Hu K, Song M, Song Y.   +6 more
europepmc   +1 more source

Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-Term Pre-exposure Prophylaxis Adherence for US Men Who Have Sex With Men in Pilot RCT. [PDF]

Clin Infect Dis
Spinelli MA, Ewart LD, Ross EJ, Heise MJ, Buccheri R, Moreira C, Mahuvakar S, Glidden DV, Amico KR, Arnold E, Rodrigues W, Okochi H, Manuel J, Handley M, Buchbinder SP, Carrico A, Gandhi M.   +16 more
europepmc   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Gurney J, Gandhi-Patel B, Unger N, Mordi U, Chen M, Jarrett J, Sherman EM, Mounzer K, Khalsa AM, Dinges WL, McKellar MS, Lipps A.   +17 more
europepmc   +1 more source

Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model. [PDF]

Braz J Med Biol Res
Chege BM, Mwangi PW, Githinji CG, Bukachi F.   +3 more
europepmc   +1 more source

Hepatitis B Virus Reactivation in People With HIV After Treatment With Non-hepatitis B Virus-Active Antiretroviral Therapy. [PDF]

Clin Infect Dis
Mohareb AM, Boyd A.
europepmc   +1 more source

Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways. [PDF]

Microbiol Spectr
Hughes SM, Calienes FL, Levy CN, Pandey U, Gornalusse GG, Cranston RD, Lama JR, Pickett J, Brand RM, Hendrix CW, Marzinke MA, Dai JY, Balar B, Justman JE, Nair G, Berard AR, Birse K, Noel-Romas L, Mayer KH, Stekler JD, Mackelprang R, Burgener AD, McGowan I, Cameron CM, Cameron MJ, Woodrow KA, Hladik F.   +26 more
europepmc   +1 more source